End-binding protein 1 stimulates paclitaxel sensitivity in breast cancer by promoting its actions toward microtubule assembly and stability

Paclitaxel is a microtubule-targeting agent widely used for the treatment of many solid tumors. However, patients show variable sensitivity to this drug, and effective diagnostic tests predicting drug sensitivity remain to be investigated. Herein, we show that the expression of end-binding protein 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Youguang, Li, Dengwen, Ran, Jie, Yan, Bing, Chen, Jie, Dong, Xin, Liu, Zhu, Liu, Ruming, Zhou, Jun, Liu, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Higher Education Press 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026418/
https://www.ncbi.nlm.nih.gov/pubmed/24748116
http://dx.doi.org/10.1007/s13238-014-0053-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026418/
https://www.ncbi.nlm.nih.gov/pubmed/24748116
http://dx.doi.org/10.1007/s13238-014-0053-0

Ejemplares similares